Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Monopar Therapeutics
Monopar Therapeutics
Monopar Drops Lead Candidate after Disappointing Phase III Analysis
BioSpace
Wed, 03/29/23 - 09:51 am
Monopar Therapeutics
clinical trials
Validive
severe oral mucositis
chemotherapy
cancer
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
Thu, 10/3/19 - 10:08 pm
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
Sat, 09/28/19 - 04:38 pm
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Monopar raises IPO Target to $46 Million
CP Wire
Wed, 09/11/19 - 09:57 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Monopar raises IPO Target to $46 Million
Wed, 09/11/19 - 09:53 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Monopar Therapeutics Files for $40 Million IPO
Fri, 08/16/19 - 02:04 pm
Monopar Therapeutics
Monopar files for $40M IPO to test chemo side effect drug
Fierce Biotech
Fri, 08/16/19 - 10:06 am
Monopar Therapeutics
IPO
chemoradiotherapy
